INTRODUCTION
Giant-cell myocarditis (GCM) is a rare disease that is characterized by diffuse inflammatory infiltration of the myocardium with lymphocytes and multi-nucleated giant cells in the absence of granulomas [1] . It most commonly presents as heart failure with ventricular arrhythmias and cardiac conduction abnormalities [1] . The clinical course in GCM is typically fulminant, with ensuing death or cardiac transplantation within hours or days of presentation, despite initiation of guideline-directed medical therapy [1] . Endomyocardial biopsy (EMB) is key in establishing the correct diagnosis, and planning further management. There is, however, no guideline-directed recommendation on re-biopsy or left ventricular (LV) EMB in a suspected case of acute, fulminant myocarditis following an indeterminate first biopsy. This manuscript illustrates, with a case, the changing role for EMB in the current era in the diagnosis of GCM.
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CASE REPORT
Informed consent was obtained from this patient for being included in the paper.
HISTORY
A 50-year-old male presented to his primary care physician in rural Minnesota (United 
PHYSICAL EXAMINATION
On physical examination, the patient's temperature was 37.3°C (99.1 K), his heart rate was irregular at 102 beats per minute, his blood pressure was 102/80 mmHg, his respiratory rate was 13 breaths per minute, and his oxygen saturation (via pulse oximetry) was 97% on 3 L/ min on inhalational oxygen via nasal cannula. The jugular venous pressure was elevated at 15 cmH 2 0. The point of maximal impulse was palpated in the 6th intercostal space, 3 cm lateral to the midclavicular line. Heart sounds were distant. There was an S3 gallop with minimal bibasilar crackles on cardiopulmonary auscultation. Hands and feet were warm with intact peripheral pulses. There was trace pedal edema. Review of systems was otherwise unremarkable. (Fig. 3) .
DIAGNOSTIC STUDIES

DISCUSSION
The diagnosis of GCM is established by a conglomerate of laboratory and radiographic was given a specific histological diagnosis from EMB [5] . Another more recent study specifically examined long-term survival rates among 147 patients diagnosed with either fulminant or acute myocarditis [6] . Biopsied specimens were taken from the RV septum, and analyzed using the Dallas criteria (inflammatory infiltrate and associated myocyte damage not characteristic of Diseases position statement also supports the aforementioned recommendation [9] . However, the sensitivity of EMB for GCM decreases with duration of symptoms [10] . In a study by Kandolin et al. [11] of 72 young adult patients aged 18-55 years with initially unexplained atrioventricular block in whom GCM was found in 6% (n = 4) of cases [19% (n = 14) were diagnosed with cardiac sarcoidosis], EMB had a 25% diagnostic rate, comparable to that reported in a prospective GCM registry (28%) where the criteria for biopsy were an acute cardiomyopathy complicated by heart block, ventricular arrhythmias, or lack of response to usual care [11, 12] . The sensitivity of RV EMB is 80-85% in GCM, and its yield is significantly improved if prior site localization is done with cMRI [10, 13] . In addition, sensitivity of EMB has been shown to increase from 68% to 93%
upon re-biopsy in GCM patients [11] . Also, LV EMB, a procedure that is rarely performed in medical centers across the United States, could have provided crucial diagnostic information in our case due to predominant LV involvement. This is supported by the recently published data on safely performing LV EMB in the largest case series to date, by Chimenti and Frustaci [14] . A total of 4,221 patients underwent EMB; 1,153 underwent LV EMB, 672 RV EMB, and 2,369 both LV and RV EMB.
The overall risk of major complications was remarkably low over the 28-year period of the study, lower with LV than RV EMB (0.33% vs. 0.45%, respectively), probably due to thinner RV free wall [13] . The diagnostic yield was higher with LV EMB, of disorders primarily affecting the left ventricle, compared to RV EMB (97.8% vs. 53%, respectively) [15] . Surprisingly enough, the diagnostic yield of LV EMB was higher for ARVC/D, a disorder that primarily affects the RV ''triangle of dysplasia'' [16] . Another study by Yilmaz et al. [17] substantially to the sensitivity of EMB for the diagnosis of myocarditis and probably GCM [18, 19] .
The diagnostic accuracy can be optimized when the EMB is performed by experienced cardiac interventionalists, sampling error reduced by performing EMB early in the course of the disease, and taking multiple samples, at least 3, each 1-2 mm in size from either the right or the left ventricle [15] , and performing immunohistochemistry and viral genome amplification for assessment of suspected myocarditis [18] .
CONCLUSION
Acute GCM is a life-threatening condition that requires prompt evaluation, initiation of immunosuppressive therapy and consideration for mechanical circulatory support or cardiac transplantation. EMB is pivotal to establish the correct diagnosis, and should be included in the diagnostic algorithm for fulminant myocarditis. The AHA/ACCF/ESC scientific statement on EMB does not discuss re-biopsy of the RV, or proceeding further to LV EMB to improve diagnostic accuracy [8] . If the results of the first RV EMB are inconclusive or discordant with the clinical scenario, then re-biopsy or LV EMB should be considered in the clinical scenario of fulminant myocarditis.
